000 02754cam a2200349 a 4500
003 EG-GiCUC
005 20250223032348.0
008 190828s2019 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.08.09.Ph.D.2019.He.E
100 0 _aHeba Mahmoud Soliman Zaki Mansour
245 1 0 _aEffect of certain drugs on thioacetamide- induced liver fibrosis in rats /
_cHeba Mahmoud Soliman Zaki Mansour ; Supervised Hala Fahmy Zaki , Rania Mohsen Abdelsalam , Naglaa Assaf Ahmed
246 1 5 _aتأثير بعض الادويه فى التليف الكبدى المستحدث بالثيواسيتاميد
260 _aCairo :
_bHeba Mahmoud Soliman Zaki Mansour ,
_c2019
300 _a169 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
520 _aLiver fibrosis is a health concern that leads to organ failure mediated via production of inflammatory cytokines and fibrotic biomarkers. This study aimed to explore the protective effect of tadalafil, a phosphodiesterase-5 inhibitor, mycophenolate mofetil, immunosuppressant drug, against thioacetamide (TAA)-induced liver fibrosis. Fibrosis was induced by administration of TAA (200 mg/kg, i.p.) twice weekly for 6 weeks. Serum transaminases activities, liver inflammatory cytokines, fibrotic biomarkers, and liver histopathology were assessed. TAA induced marked histopathological changes in liver tissues coupled with elevations in serum transaminases activities. Furthermore, hepatic content of nitric oxide and tumor necrosis factor-alpha, interleukin-6, and interleukin-1 beta were elevated, together with a reduction of interleukin-10 in the liver. In addition, TAA increased hepatic contents of transforming growth factor-beta, hydroxyproline, alpha-smooth muscle actin, and gene expression of collagen-1. Pretreatment with tadalafil or mycophenolate mofetil protected against TAA-induced liver fibrosis, in a dose-dependent manner, as proved by the alleviation of inflammatory and fibrotic biomarkers. The effects of tadalafil or mycophenolate mofetil were comparable with that of silymarin, a natural antioxidant, and could be assigned to its anti-inflammatory and anti-fibrotic properties
530 _aIssued also as CD
653 4 _aLiver fibrosis
653 4 _aTadalafil
653 4 _aThioacetamide
700 0 _aHala Fahmy Zaki ,
_eSupervisor
700 0 _aNaglaa Assaf Ahmed ,
_eSupervisor
700 0 _aRania Mohsen Abdelsalam ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aAsmaa
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c73531
_d73531